Financhill
Back

Myriad Genetics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
19

MYGN
Myriad Genetics

Last Price:
$13.67
Seasonality Move:
3.46%
Sell
25

CATX
Perspective Therapeutics

Last Price:
$3.50
Seasonality Move:
43.39%
Sell
19
Myriad Genetics (MYGN) is a Sell

Is Myriad Genetics a Buy, Sell or Hold?

  • The current Myriad Genetics [MYGN] share price is $13.67. The Score for MYGN is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • MYGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.51. The Score for CATX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MYGN Stock Price Chart

What is Myriad Genetics's stock price today?

  • The Myriad Genetics share price today is $13.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

MYGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.85 Sell
Relative Strength Index (14 RSI): 35.58 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.37 - 15.73) Sell
Bollinger Bands (100): (15.79 - 27.13) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 37.48 Sell
Chaikin Money Flow: 704863 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.07 - 3.87) Buy
Bollinger Bands (100): (5.54 - 14.76) Sell

MYGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.6 Buy
20-day SMA: 14.08 Sell
50-day SMA: 16.25 Sell
200-day SMA: 22.37 Sell
8-day EMA: 13.64 Buy
20-day EMA: 14.21 Sell
50-day EMA: 16.54 Sell
200-day EMA: 20.87 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.24 Buy
20-day SMA: 3.32 Buy
50-day SMA: 6.48 Sell
200-day SMA: 11.89 Sell
8-day EMA: 3.27 Buy
20-day EMA: 3.68 Sell
50-day EMA: 5.95 Sell
200-day EMA: 9.5 Sell

Myriad Genetics Earnings Growth & MYGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.31 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.35 per share.

Myriad Genetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):